Adjuvanted Hepatitis B vaccine (Recombinant) (Dynavax)

Product Name :
Adjuvanted Hepatitis B vaccine (Recombinant) (Dynavax)

Search keywords :
HBsAg

drugId :
null

Target Vo:
Toll like receptor 9

Target Vo Short Name :
TLR9

Moa_Name:
Immunostimulants

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Dynavax Gmbh

Active Company_Name :
Bavarian Nordic A/S

Active Indication_Name:
Hepatitis B

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD68 Antibody (YA799)
Collagen I alpha 2 Antibody
PAK2 Antibody (YA695): PAK2 Antibody (YA695) is a non-conjugated and Mouse origined monoclonal antibody about 58 kDa, targeting to PAK2 (7H3). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Monkey.

Author: Betaine hydrochloride

Related Posts